Piezo1 participates in sevoflurane-induced developmental neurotoxicity via neuroinflammation and synaptic damage in the hippocampus
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115284 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yang Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China. Hauptthemen laut MEDLINE: Sevoflurane, Hippocampus, Neuroinflammatory Diseases, Neurotoxicity Syndromes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Multiple exposures to sevoflurane in developmental neonatal mice lead to neurocognitive deficits. The present study investigates the role and mechanisms of Piezo1 in sevoflurane-induced developmental neurotoxicity. METHODS: Neonatal mice received sevoflurane on postnatal days (P) 6, 7, and 8. Piezo1 function was assessed using inhibitor GsMTx4 and agonist Yoda1. Cognitive function was evaluated via behavioral tests. Neuroinflammation was assessed by ELISA, Western blot, and immunofluorescence. Synaptic integrity was analyzed by Golgi staining. RESULTS: Sevoflurane induced cognitive deficits, neuroinflammation, and synaptic damage, and increased Piezo1 expression. Yoda1 exacerbated cognitive deficits. GsMTx4 rescued cognitive function and synaptic plasticity, reduced microglial phagocytosis, and suppressed complement activation. In vitro, sevoflurane increased Piezo1 expression and intracellular calcium flux in BV2 microglia; GsMTx4 blocked these effects. Yoda1 amplified calcium flux, pro-inflammatory cytokines (TNF-α/IL-6), and C1q expression, which were abolished by calcium chelator BAPTA-AM. CONCLUSION: Piezo1 mediates sevoflurane-induced developmental neurotoxicity via calcium-dependent microglial complement signaling and synaptic phagocytosis. Piezo1 inhibition is considered a potential therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.
- Department of Anesthesiology, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China; Brain and Neurological Research Laboratory, Bengbu Medical University, Bengbu 233000, China.
- Department of Anesthesiology, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China; Key Laboratory of Cardio-Cerebrovascular Foundation and Clinical Sciences, Bengbu Medical University, Bengbu 23…
- Department of Anesthesia, Bengbu Medical University, Bengbu 233000, China.
- Department of Clinical Laboratory Medicine, Bengbu Medical University, Bengbu 233000, China.
- Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hongkong 999077, China.
Zitieren
APA
Zhang, Y., Liu, X., Gao, Y., Fu, C., Xue, Y., Wang, D., Hong, J., Ren, L., Zha, L., Ling, Y., Zhang, C., & Li, X. (2025). Piezo1 participates in sevoflurane-induced developmental neurotoxicity via neuroinflammation and synaptic damage in the hippocampus. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115284
Vancouver
Zhang Y, Liu X, Gao Y, Fu C, Xue Y, Wang D, et al. Piezo1 participates in sevoflurane-induced developmental neurotoxicity via neuroinflammation and synaptic damage in the hippocampus. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115284
BibTeX
@article{Zhang2025,
author = {Zhang, Yang and Liu, Xinru and Gao, Ying and Fu, Chengwen and Xue, Yanan and Wang, Dongsheng and Hong, Jin and Ren, Li and Zha, Liwen and Ling, Yunzhi and Zhang, Congli and Li, Xiaohong},
title = {Piezo1 participates in sevoflurane-induced developmental neurotoxicity via neuroinflammation and synaptic damage in the hippocampus},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115284}
}
EUVIMED